PMID- 16940747 OWN - NLM STAT- MEDLINE DCOM- 20061213 LR - 20231213 IS - 1018-2438 (Print) IS - 1018-2438 (Linking) VI - 141 IP - 4 DP - 2006 TI - Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. PG - 354-68 AB - BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with an abnormal inflammatory response of the lungs to noxious particles or gases. We investigated whether Toll-like receptor 4 (TLR4) is implicated in cigarette smoke (CS)-induced pulmonary inflammation in a murine model of COPD. METHODS: C3H/HeOuJ (Tlr4(WT)) and C3H/HeJ (Tlr4(defective)) mice were exposed to air or CS for 5 weeks (subacute) and 26 weeks (chronic), and pulmonary inflammation was evaluated. RESULTS: In Tlr4(WT) mice, subacute and chronic CS exposure induced a substantial pulmonary infiltration of macrophages, neutrophils, lymphocytes and dendritic cells (DCs), that was absent in air-exposed mice. CS exposure increased the costimulatory marker expression on DCs, the levels of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) in bronchoalveolar lavage (BAL) fluid and induced the pulmonary expression of matrix metalloproteinase-12 (MMP-12), TLR4 and TLR2. In contrast, after subacute CS exposure, Tlr4(defective) mice showed a limited (5-fold lower) increase of DCs and lymphocytes in BAL fluid, lower costimulatory marker expression on DCs and lower MCP-1 and TNF-alpha levels in BAL fluid compared to Tlr4(WT) animals. After chronic CS exposure, however, the difference in pulmonary inflammation between Tlr4(WT) and Tlr4(defective) mice was less pronounced and both strains showed similar MCP-1 and TNF-alpha levels in BAL and similar pulmonary MMP-12, TLR4 and TLR2 expression. CONCLUSIONS: We demonstrated that the TLR4 mutation in C3H/HeJ mice is protective against CS-induced pulmonary influx of neutrophils, DCs and lymphocytes upon subacute CS exposure. However, TLR4 is only of minor importance in chronic CS-induced inflammation in mice. FAU - Maes, Tania AU - Maes T AD - Department of Respiratory Diseases, Ghent University Hospital, Ghent, Belgium. tania.maes@Ugent.be FAU - Bracke, Ken R AU - Bracke KR FAU - Vermaelen, Karim Y AU - Vermaelen KY FAU - Demedts, Ingel K AU - Demedts IK FAU - Joos, Guy F AU - Joos GF FAU - Pauwels, Romain A AU - Pauwels RA FAU - Brusselle, Guy G AU - Brusselle GG LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060829 PL - Switzerland TA - Int Arch Allergy Immunol JT - International archives of allergy and immunology JID - 9211652 RN - 0 (CD11c Antigen) RN - 0 (Ccl2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Smoke) RN - 0 (Tlr2 protein, mouse) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 2) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.24.65 (Matrix Metalloproteinase 12) SB - IM MH - Animals MH - Bronchoalveolar Lavage Fluid/cytology MH - CD11c Antigen/analysis MH - Chemokine CCL2/biosynthesis MH - Dendritic Cells/physiology MH - Inflammation/*etiology MH - Lung/*pathology MH - Male MH - Matrix Metalloproteinase 12/biosynthesis MH - Mice MH - Mice, Inbred C3H MH - Pulmonary Disease, Chronic Obstructive/*etiology MH - Smoke/*adverse effects MH - Nicotiana/*adverse effects MH - Toll-Like Receptor 2/biosynthesis MH - Toll-Like Receptor 4/*physiology MH - Tumor Necrosis Factor-alpha/biosynthesis EDAT- 2006/08/31 09:00 MHDA- 2006/12/14 09:00 CRDT- 2006/08/31 09:00 PHST- 2005/09/07 00:00 [received] PHST- 2006/04/20 00:00 [accepted] PHST- 2006/08/31 09:00 [pubmed] PHST- 2006/12/14 09:00 [medline] PHST- 2006/08/31 09:00 [entrez] AID - 95462 [pii] AID - 10.1159/000095462 [doi] PST - ppublish SO - Int Arch Allergy Immunol. 2006;141(4):354-68. doi: 10.1159/000095462. Epub 2006 Aug 29.